Skip to content

The use of an iodine 125 marker for perioperative localization in primary hyperparathyroidism, a pilot study.

The use of an iodine 125 marker for perioperative localization in primary hyperparathyroidism, a pilot study. - I-125 marker localization in primary hyperparathyroidism.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36945
Enrollment
10
Registered
2012-11-30
Start date
2013-12-02
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parathyroid tumor primary hyperparathyroidism

Interventions

The placement of an I-125 marker for the localization of a parathyroid gland ultrasound guided.

Sponsors

Amphia Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: primary hyperparathyroidism, age >18 year, and a parathyroid adenoma that can be localised by ultrasound in the neck

Exclusion criteria

Exclusion criteria: age

Design outcomes

Primary

MeasureTime frame
All data are recorded prospectively. Patient characteristics, indication for surgery (MIP), placement of the I-125 marker (complications, time, difficulty, displacement of the marker), intraoperative data (time to find the marker, blood loss, operative time, use of NIM, occurring of migration, distance to parathyroid / thyroid) and the results of the final pathologic study (diagnosis, radical, effect on parathyroid / thyroid) will be recorded. All data will be analyzed and processed in SPSS. It is a prospective study to describe the feasability of I-125 markers in parathryoid surgery.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)